Harbour Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $197K | Sell |
2,519
-92
| -4% | -$7.2K | 0.01% | 1184 |
|
|
2025
Q1 | $189K | Sell |
2,611
-3
| -0.1% | -$217 | 0.01% | 1118 |
|
|
2024
Q4 | $194K | Sell |
2,614
-140
| -5% | -$10.4K | 0.01% | 1068 |
|
|
2024
Q3 | $182K | Sell |
2,754
-4
| -0.1% | -$264 | 0.01% | 1050 |
|
|
2024
Q2 | $255K | Sell |
2,758
-12
| -0.4% | -$1.11K | 0.01% | 853 |
|
|
2024
Q1 | $265K | Sell |
2,770
-862
| -24% | -$82.4K | 0.01% | 813 |
|
|
2023
Q4 | $277K | Buy |
3,632
+471
| +15% | +$35.9K | 0.01% | 731 |
|
|
2023
Q3 | $219K | Buy |
3,161
+590
| +23% | +$40.9K | 0.01% | 761 |
|
|
2023
Q2 | $243K | Buy |
2,571
+11
| +0.4% | +$1.04K | 0.01% | 725 |
|
|
2023
Q1 | $212K | Sell |
2,560
-4
| -0.2% | -$331 | 0.01% | 750 |
|
|
2022
Q4 | $191K | Sell |
2,564
-121
| -5% | -$9.03K | 0.01% | 756 |
|
|
2022
Q3 | $255K | Hold |
2,685
| – | – | 0.02% | 605 |
|
|
2022
Q2 | $255K | Buy |
+2,685
| New | +$255K | 0.02% | 605 |
|
|
2021
Q4 | $466K | Sell |
3,595
-3,564
| -50% | -$462K | 0.03% | 444 |
|
|
2021
Q3 | $810K | Sell |
7,159
-3,865
| -35% | -$437K | 0.03% | 500 |
|
|
2021
Q2 | $1.14M | Sell |
11,024
-111
| -1% | -$11.5K | 0.04% | 423 |
|
|
2021
Q1 | $931K | Buy |
+11,135
| New | +$931K | 0.03% | 430 |
|